Author: user

Micron Technology (NASDAQ: MU) stock surged nearly 80% in early 2024 and reached an all-time high of $153.14 on solid adoption of its high-performance memory products in the data economy. Despite this success, the stock is currently down by almost 32% from those highs. Investors were disappointed with the company’s fiscal 2024 third-quarter results (ended May 30), especially AI sales which fell short of lofty expectations. Furthermore, geopolitical and supply chain challenges plaguing the overall semiconductor industry also did not help overall investor sentiment for Micron. Start Your Mornings Smarter! Wake up with Breakfast news in your inbox every market day. Sign…

Read More

SAN RAFAEL, Calif., Nov. 16, 2024 /PRNewswire/ —  BioMarin Pharmaceutical (TADAWUL:) Inc. (Nasdaq: BMRN) today announced positive and consistent results from multiple real-world evidence studies of VOXZOGO ®  (vosoritide) in children with achondroplasia. These results, as well as data from the investigational research program for VOXZOGO in hypochondroplasia, were presented at the 62nd Annual European Society for Paediatric Endocrinology (ESPE) Meeting  in Liverpool, England, Nov. 16-18, 2024.   “The extensive clinical data supporting VOXZOGO in children with achondroplasia are well-known, and at ESPE, we shared further results in children who greatly benefited from the medicine in a real-world setting,” said…

Read More

Image source: Getty Images The UK has some great shares for passive income investors to consider buying. But distributing cash to investors isn’t always the right thing for a company to do.  Sometimes, a business can use its cash in a way that significantly improves its long-term outlook. And in that situation, it’s best for investors if it doesn’t pay it out as a dividend. Forterra One example is Forterra (LSE:FORT), which I used to hold. The stock has a dividend yield of 1.66%, but I don’t think it should be sending cash out to shareholders at the moment. The…

Read More

By Danielle Broadway OAKLAND, California (Reuters) – South Korean boy band Seventeen had fans chanting their names in Oakland, California last week as part of their “Right Here” world tour to promote the group’s 2024 album “17 Is Right Here.” “I’ve been a Seventeen fan about six or seven years,” said Ruby Webb, a 21-year-old fan from Portland, Oregon. “I love them [Seventeen] so much. S.Coups, Mingyu, Dino, they’re my babies,” she added. While there was excitement, the fans known as Carats, spoke about the recent controversy with the South Korean company HYBE, that oversees several K-Pop artists, including popular…

Read More

Money manager John Davi is positioning for challenges tied to President-elect Donald Trump’s tariff agenda.Davi said he worries the new administration’s policies could be “very inflationary,” so he thinks it is important to choose investments carefully.”Small-cap industrials make more sense than large-cap industrials,” the Astoria Portfolio Advisors CEO told CNBC’s “ETF Edge” this week.Davi, who is also the firm’s chief investment officer, expects the red sweep will help push a pro-growth, pro-domestic policy agenda forward that will benefit small caps.It appears Wall Street agrees so far. Since the presidential election, the Russell 2000 index, which tracks small-cap stocks, is up around…

Read More

We came across a bullish thesis on Gildan Activewear Inc. (GIL) on ValueInvestorsClub by komrade.kapital. In this article, we will summarize the bulls’ thesis on GIL. GIL’s stock was trading at $39.48 when this thesis was published, vs. a closing price of $48.85 on November 12. Gildan, incorporated in 1984, is a vertically integrated manufacturer and distributor of low-cost T-shirts, fleece, and other apparel in the North American region. With a dual-channel approach of distributors and retailers, GIL is the market leader in the open-end t-shirt segment, which occupies 80% of the market. Currently, GIL aims to capture a large portion of…

Read More

Your 401(k) could probably use a checkup. Donald Trump’s victory in the US election sent stocks surging to all-time highs and raised the prospect of sweeping policy changes from taxes to healthcare. The Federal Reserve just cut rates again, a mounting US budget deficit has hawks worried about higher inflation and Social Security could face benefit cuts of about 20% within a decade. Source link

Read More

Is the dragon slain? Or just wounded? Inflation has been the scourge of the economy for the last three years. It spiked from a benign 1.4% when President Biden took office in 2021 to a searing 9% some 18 months later. The Federal Reserve took aim with speedy interest rate hikes, and it seemed to work. By September, inflation was down to 2.4%, almost in the normal zone. Then, an upward blip. The latest data shows inflation ticked back up to 2.6% in October. That could be a spot on the X-ray that turns out to be nothing. Or it…

Read More

Image source: Getty Images I own quite a few FTSE 100 shares with juicy yields. British American Tobacco, Legal & General, and M&G (LSE: MNG) all offer a dividend yield higher than 8% right now, for example. But that is more than double the current average for shares in the flagship blue-chip index of British shares. So, ought I to tack to the average – or find shares that offer an exceptional yield? Dividends – and the rest Of course, the prospect of earning £8 or more each year for every £100 I invest today is attractive. Not only do…

Read More